Washington [US], March 9 (ANI): Pharmaceutical company Pfizer on Tuesday (local time) stated that it has started the Phase 2/3 clinical study to evaluate the safety and efficacy of its COVID-19 oral treatment in the pediatric population at risk of progression to severe disease.
Seoul [South Korea], December 28 (ANI/Global Economic): 'Paxlovid,' the COVID-19 oral treatment developed by a global pharmaceutical company Pfizer, received emergency use authorization from the Ministry of Food and Drug Safety (MFDS) on the 27th. It is expected to be used from the end of Ja